Reply to: S. N. Katkuri et al. and H. Liu et al. on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).

Saved in:
Bibliographic Details
Title: Reply to: S. N. Katkuri et al. and H. Liu et al. on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).
Authors: Mullol J; Rhinology Unit & Smell Clinic, Department of Otorhinolaryngology, Hospital Clinic Barcelona, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Catalonia, Spain., Han JK; Department of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia, USA., Laidlaw TM; Division of Allergy and Clinical Immunology, Department of Medicine, Jeff and Penny Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Hopkins C; Department of Otolaryngology-Head and Neck Surgery, Guy's and St Thomas' Hospital, London, UK., Peters AT; Division of Allergy and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Pfaar O; Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps University of Marburg, Marburg, Germany., Desrosiers M; Division of Otolaryngology, Head and Neck Surgery, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada., Lee SE; Division of Otolaryngology, Head and Neck Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Lane AP; Department of Otolaryngology, Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Chen C; Biometrics, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA., Chon Y; Global Biostatistical Science, Amgen, Thousand Oaks, California, USA., Ponnarambil SS; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Foster A; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA., Lindsley AW; US Medical Affairs, Amgen, Thousand Oaks, California, USA., Ambrose CS; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA.
Source: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2026 May; Vol. 16 (5), pp. 534-536. Date of Electronic Publication: 2026 Apr 17.
Publication Type: Letter
Journal Info: Publisher: Published for ARS-AAOA by Wiley-Blackwell Country of Publication: United States NLM ID: 101550261 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-6984 (Electronic) Linking ISSN: 20426976 NLM ISO Abbreviation: Int Forum Allergy Rhinol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:2042-6984
DOI:10.1002/alr.70168